GI
IGMS

GAMMA Investing’s IGM Biosciences IGMS Stock Holding History

GAMMA Investing’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-251
Closed -$1.53K – 3834
2024
Q4 		$1.53K Buy
251
+182
+264% +$2.16K ﹤0.01% 3298
2024
Q3 		$1.14K Buy
+69
New +$756 ﹤0.01% 3223
2024
Q2 		– Sell
-76
Closed -$733 – 3486
2024
Q1 		$733 Buy
+76
New +$881 ﹤0.01% 3014

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

GAMMA Investing's IGMS Position: Q1 2025 in Review

GAMMA Investing sold out of IGM Biosciences (IGMS) in Q1 2025, closing a stake of 251 shares — an estimated $1.53K sold.

GAMMA Investing first reported a position in IGMS in Q1 2024 and held it in 3 quarters. The position peaked at $1.53K in Q4 2024. 79 funds tracked by Wall St. Rank hold IGMS as of Q1 2025.

  • GAMMA Investing reported no remaining IGM Biosciences position as of Q1 2025 after selling out during the quarter.
  • GAMMA Investing sold 251 IGM Biosciences shares in Q1 2025, an estimated $1.53K.
  • GAMMA Investing first reported a position in IGM Biosciences in Q1 2024 and held it in 3 quarters.
  • GAMMA Investing's IGM Biosciences position peaked at $1.53K in Q4 2024.
  • 79 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2025.

Based on GAMMA Investing's 13F filing for Q1 2025, filed 7 Apr 2025.